Transforming Chronic Care: An Interview with Rishi Tandulwadkar, founder of ALIV

An Exclusive Interview with Rishi Tandulwadkar, founder and health innovator behind ALIV, India’s first clinically supervised preventive and regenerative wellness centre

In this exclusive interview, Rishi Tandulwadkar, founder of ALIV—India’s pioneering clinically supervised preventive and regenerative wellness center—shares his visionary journey.

From winning global acclaim at the G20 to revolutionizing stem cell therapies for chronic ailments, he unveils the future of doctor-led healing.

What personal experiences or challenges in healthcare inspired you to launch ALIV Regenerative Wellness?

Rishi Tandulwadkar: Watching my nani age is what made this personal. She was the most social, active person in our family, and then slowly her world shrank. Mobility reduced, body function dropped, and comorbidities piled on.

As a teenager and then in my early 20s, seeing that decline up close felt unfair, because the default approach around us was always reactive: manage symptoms, accept “this is aging,” and intervene late.

When kidney failure became a looming reality, it pushed us to explore regenerative medicine seriously.

The challenge back then was that the science existed mostly in labs, but there weren’t many clinicians translating it into safe, structured care. So my parents decided to become that bridge, combining scientific inputs with careful patient selection, informed consent, and ethical practice.

ALIV grew from that journey. It’s not about promising miracles. It’s about building a longevity and preventive healthcare model in India that helps people protect function, resilience, and quality of life earlier; before a crisis becomes the only option.

Can you describe ALIV’s core mission and the unique technologies or therapies it offers for wellness and recovery?

Rishi Tandulwadkar: Modern life is changing human biology fast: stress, poor sleep, less sunlight, sedentary routines, processed food, screen load, metabolic strain. So ALIV’s mission is to help people stay functional and resilient for longer by working upstream, not at the last stage of disease.

We build our approach around five pillars: repair, regeneration, inflammation control, metabolic health, and gene regulation (epigenetic support).

That’s the lens we use to personalize programs; short-term goals like energy, recovery, weight support, and performance, and long-term goals like healthy aging and independence.

Clinically, we combine doctor-led targeted IV drip therapy with autologous cell therapy (using the patient’s own biology) where appropriate, always with safety frameworks and realistic expectations. ALIV’s focus is structured, ethical regenerative wellness; not “one-size-fits-all” protocols.

What milestones has ALIV achieved since its inception, including any key product launches or clinical validations?

Rishi Tandulwadkar: A few milestones matter because they show the arc: research first, outcomes next, recognition later.

● December 2015: The regenerative work began in Pune with early lab and clinical groundwork.

● 2016–2018: Our infertility work gained wide attention after a published report describing a successful birth in a 45-year-old perimenopausal woman using an autologous bone-marrow derived stem cell approach as part of assisted reproduction (reported in 2018 by Dr. Sunita Tandulwadkar and colleagues). 

● June 2024: Represented India at the G20 Young Entrepreneurs’ Alliance Summit (Goiânia, Brazil) and won the Best Entrepreneur Pitch Award, helping bring global visibility to India’s clinician-led preventive + regenerative care vision. 

Beyond headlines, the real milestone is the compounding learning from years of patient outcomes and iteration; done carefully, ethically, and under medical supervision.

Winning the best entrepreneur pitch at the G20 YEA Summit in Brazil must have been thrilling—how did that opportunity arise, and what did your pitch focus on?

Rishi Tandulwadkar: I never chased pitch competitions because we weren’t building ALIV to raise funding. We were building it to prove outcomes and scale responsibly.

This happened because someone who knew my journey- Mr. Vishal Agarwalla submitted a synopsis of my work and ALIV to the committee without telling me.

From thousands of applicants, we got shortlisted, and it kept narrowing until I was selected to present. I found out very late, and we built the deck in two days for a three-minute pitch.

The pitch wasn’t hype. It focused on why longevity and preventive healthcare must be clinician-led, why ethical regenerative wellness needs structure (not shortcuts), and how autologous biology + targeted therapies can support function and quality of life.

When people realized this wasn’t a concept but years of real-world learning, it resonated; because chronic lifestyle disease is universal, wherever you live.

How has representing India at the G20 event influenced ALIV’s growth trajectory and international partnerships?

Rishi Tandulwadkar: It accelerated credibility overnight, but more importantly it clarified the conversation. Globally, many people still think regenerative medicine must mean “cure.” A huge, practical frontier today is quality of life: supporting function, recovery, and resilience while science continues evolving.

After G20YEA, we received inbound interest from multiple geographies for collaboration, knowledge exchange, and even lab-model replication. We’re cautious, regulation (or lack of it) is

exactly where this field can go wrong. So we only explore partnerships that align with physician oversight, ethical practice, informed consent, and standardization.

It also helped shift the narrative in India. Many people assume ALIV is “IV drip therapy.” IV is one tool. The bigger mission is engineering preventive healthcare for modern life: longevity-focused, science-backed, and grounded in responsible medicine.

As a leader in regenerative wellness, what are the two non-negotiable personal wellness practices in your own life?

Rishi Tandulwadkar: One: I protect metabolic stability. Especially avoiding blood sugar spikes. If your glucose is constantly swinging, everything suffers: energy, mood, sleep, inflammation, and recovery.

I keep it simple: structured eating, consistent movement, and habits that keep my system steady.

Two: I deliberately reset my nervous system: travel, nature, and real connection. Longevity isn’t only about supplements or labs. Emotional health, community, curiosity, and time away from constant output directly shape how you feel and function.

When your mind is regulated, your body performs better; this is one of the most underrated forms of “preventive medicine.”

Rishi Tandulwadkar’s insights affirm ALIV’s mission to transform wellness through regenerative innovation, not mere business. As India’s trailblazer in supervised therapies, his blueprint promises hope for millions battling Parkinson’s and beyond, urging a shift to proactive health

Read more Success stories of Indian entrepreneurs, Women Entrepreneurs & startups stories at SugerMint. Follow us on Twitter, Instagram, Facebook, LinkedIn